QR Pharma Inc. Exclusively Licenses Clinical Stage Compounds Posiphen®, Bisnorcymserine and Phenserine to Treat Alzheimer’s Disease

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply